Loading...
LeMaitre Vascular, Inc.
LMAT•NASDAQ
Healthcare
Medical - Instruments & Supplies
$82.43
$1.66(2.06%)
LeMaitre Vascular, Inc. (LMAT) Financial Performance & Income Statement Overview
Review LeMaitre Vascular, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
13.63%
↑ 13.63%
Operating Income Growth
42.34%
↑ 42.34%
Net Income Growth
46.28%
↑ 46.28%
Operating Cash Flow Growth
20.06%
↑ 20.06%
Operating Margin
23.43%
↑ 23.43%
Gross Margin
68.80%
↑ 68.80%
Net Profit Margin
19.96%
↑ 19.96%
ROE
13.53%
↑ 13.53%
ROIC
9.98%
↑ 9.98%
LeMaitre Vascular, Inc. (LMAT) Income Statement & Financial Overview
Review LeMaitre Vascular, Inc.'s (LMAT) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $55.72M | $54.82M | $55.85M | $53.48M |
| Cost of Revenue | $17.13M | $17.64M | $18.85M | $16.81M |
| Gross Profit | $38.59M | $37.18M | $37.00M | $36.66M |
| Gross Profit Ratio | $0.69 | $0.68 | $0.66 | $0.69 |
| R&D Expenses | $3.62M | $3.66M | $4.28M | $4.09M |
| SG&A Expenses | $22.12M | $20.37M | $18.33M | $20.70M |
| Operating Expenses | $25.74M | $24.03M | $22.62M | $24.79M |
| Total Costs & Expenses | $42.86M | $41.67M | $41.47M | $41.60M |
| Interest Income | $1.61M | $1.20M | $1.14M | $1.001M |
| Interest Expense | $205000.00 | $0.00 | $0.00 | |
| Depreciation & Amortization | $2.48M | $2.43M | $2.38M | $2.38M |
| EBITDA | $20.16M | $15.57M | $16.76M | $14.26M |
| EBITDA Ratio | $0.36 | $0.28 | $0.30 | $0.27 |
| Operating Income | $12.85M | $13.15M | $14.38M | $11.87M |
| Operating Income Ratio | $0.23 | $0.24 | $0.26 | $0.22 |
| Other Income/Expenses (Net) | $1.17M | $1.40M | $1.13M | $923000.00 |
| Income Before Tax | $14.02M | $14.55M | $15.51M | $12.80M |
| Income Before Tax Ratio | $0.25 | $0.27 | $0.28 | $0.24 |
| Income Tax Expense | $2.84M | $3.41M | $3.68M | $2.91M |
| Net Income | $11.18M | $11.14M | $11.83M | $9.89M |
| Net Income Ratio | $0.20 | $0.20 | $0.21 | $0.18 |
| EPS | $0.50 | $0.50 | $0.53 | $0.44 |
| Diluted EPS | $0.49 | $0.49 | $0.52 | $0.44 |
| Weighted Avg Shares Outstanding | $22.51M | $22.48M | $22.46M | $22.36M |
| Weighted Avg Shares Outstanding (Diluted) | $22.90M | $22.84M | $22.73M | $22.57M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan